Omkar Pharmachem — Quarterly Results & Earnings

₹26.83

+0.00%

Profit Growth YoY-40.00%Latest quarter

Sales Growth YoY0.00%Latest quarter

Sales CAGR 5Y60.95%5 year compound

Profit CAGR 5Y22.59%5 year compound

📋

Quarterly Performance

YoY Profit Growth-40.00%

🔴 Significant decline

YoY Sales Growth+0.00%

⚠️ Mild contraction

OPM 5Y Average

Operating profit margin

49.79%

EPS Growth 5Y

22.59%

Interest Coverage

Higher = safer debt servicing

14.50

ROE

2.14%

ROCE

3.04%

💡

Growth Analysis

Omkar Pharmachem reported YoY profit growth of -40.00% and revenue growth of 0.00% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 60.95% and profits at 22.59% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Omkar Pharmachem

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Commodity Chemicals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.